Bioton is an innovative biotechnology company headquartered in Poland. Bioton is committed to providing safe and total treatment solutions for diabetics. As the second largest comprehensive pharmaceutical enterprise in Poland and the fourth listed recombinant human insulin manufacturer in the world, Bioton is the first and only company in Poland that can fully transform its technology into commercial use, thereby constantly promoting biotechnology development in Poland.
For more than two decades, Bioton has been providing daily support for diabetics around the world. Today, insulin products produced by Bioton are sold in more than 20 countries in Europe, South America, Asia and Africa. To meet different needs of its partners, the company provides finished insulin products and API, as well as technology transfer. Through technology development, education and scientific support for local communities, Bioton constantly improves the availability of insulin in other countries.